Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2719926 | The American Journal of Medicine | 2010 | 5 Pages |
Abstract
Clinicians should be highly vigilant to identify individuals with nonexposed osteonecrosis, as the impact on epidemiological data and clinical trial design could be potentially significant. Although the present case series represents approximately 30% of all patients with bisphosphonates-associated osteonecrosis observed at the study centers, further population-based prospective studies are needed to obtain robust epidemiological figures.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Stefano DDS, PhD, Stephen R. MD, PhD, Francesco MDM, MSc, PhD, Suad DDS, MSc, Paolo MD, PhD, Maddalena DDS, PhD, Paolo G. DDS, MSc, Roberto DDS, MSc, Anna DDS, PhD, Olga DDS, PhD, Tony S. DMD, Giuseppina DDS, PhD, Naom DDS, MSc,